chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pleurisy of my lungs, or known as Pleuritis.  I was treated but undiagnosed in the ER. I experienced sudden sharp chest pain and shortness of breath. I thought it was a cardiac event. The ER did not figure out what it was. My doctor was able to diagnose it a day or so later. Almost 3 full weeks now and I still have symptoms, mostly pain in my chest.
This spontaneous case was reported by a consumer and describes the occurrence of in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included SERTRALINE HYDROCHLORIDE (SERTAC) for an unknown indication. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment medications provided by the reporter.
Initial report received on 24-OCT-2013 from a consumer (the patient herself): A 62-year-old female patient with a medical history of hypothyroidism treated by SYNTHROID and seasonal allergies treated with ALLEGRA with no illness at time of vaccination had received an intramuscular dose of FLUZONE (Sanofi Pasteur Inc., batch number not reported) in the deltoid on 18-OCT-2013. This was the first time she had ever received a flu shot. On 18-OCT-2013, 4 hours after vaccination, the patient developed tongue oral mucus membrane, eyelid and facial swelling. She also had headache lasting 2 days, vomiting, chills and sweats, leg cramps of both lower extremities from knees to the ankles. The patient also stated she developed a rash on the heat sensor areas of her body however she stated this happens every time she has a fever. Her body temperature was reported as 99.8 (i.e. 37.6 degrees C). According to the patient, the symptoms lasted 3 hours. The patient self-medicated with OTC pain relief/fever reducer, medicine for headache and fever for 2 days. Patient did not seek physician evaluation or treatment. Patient stated symptoms have resolved (unspecified date).
The patient reported that she had a reaction when given the vaccine, but didn't provide what her reaction actually was.
Received Moderna covid19 vaccine and wants to Know if some of the symptoms that they are having if is normal if they are still going on; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Received Moderna covid19 vaccine and wants to Know if some of the symptoms that they are having if is normal if they are still going on) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Received Moderna covid19 vaccine and wants to Know if some of the symptoms that they are having if is normal if they are still going on). At the time of the report, VACCINATION COMPLICATION (Received Moderna covid19 vaccine and wants to Know if some of the symptoms that they are having if is normal if they are still going on) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment information were reported by the reporter
Approximately 2 months after the vaccine the patient began to have pain in his right calf. No treatment at that time. About 2 weeks later the pain came back, an ultrasound was done and blood clots were seen. Zorelto was started however patient had a reaction to that of( lips swelling and nausea). At that time Eliquis was started at 5mg BID until current.
difficulty breathing; lost of taste; lost appetite; body aches; runny nose; dry mouth; tongue is sore; she dropped 5 pounds; fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (difficulty breathing), AGEUSIA (lost of taste), DECREASED APPETITE (lost appetite), PAIN (body aches) and RHINORRHOEA (runny nose) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced DYSPNOEA (difficulty breathing), AGEUSIA (lost of taste), DECREASED APPETITE (lost appetite), PAIN (body aches), RHINORRHOEA (runny nose), DRY MOUTH (dry mouth), GLOSSODYNIA (tongue is sore), WEIGHT DECREASED (she dropped 5 pounds), FATIGUE (fatigue) and CHILLS (chills). At the time of the report, DYSPNOEA (difficulty breathing), AGEUSIA (lost of taste), DECREASED APPETITE (lost appetite), PAIN (body aches), RHINORRHOEA (runny nose), DRY MOUTH (dry mouth), GLOSSODYNIA (tongue is sore), WEIGHT DECREASED (she dropped 5 pounds), FATIGUE (fatigue) and CHILLS (chills) outcome was unknown.            Concomitant product use was not provided by the reporter.  Treatment information was not provided.
I have blurry vision in my left eye. Diagnosis by a Retina specialist and a Neuro Ophthalmologist suggests that its a case of Optic Neuritis.
Within 90 minutes of injection, throat began to swell became red and hurt. Eyes ran, fever, chills, body aches, lasted throughout the night. Swelling of throat and soreness began to subside approximately 12 hours later. Did not feel fully recovered until 2 days later.
28DEC90 TD given pt states she had no problems until JAN 4,5, & 6 91. Lt DM area started swelling hot & fevered 1 wk p/immun. Applied hot & cold compresses & took Tylenol. 7JAN91 slightly red w/some fever arm area. Redness 4" across 5"down.
Developed hives all over my body, tried Benadryl to help symptoms, minimal relief.
Pfizer COVID-19 Vaccine EUA Event Description: Patient at hospital to receive her first dose of Pfizer Covid vaccine in left deltoid at ~1105.  ~15 minutes after administration c/o leftl arm feeling hot and appearing red.  Patient was observed for 45 minutes and given Benadryl 25 mg IM, Solumedrol 125 mg IM, and Pepcid 20 mg po.  The redness on her arm increased and her BP and pulse continued to be elevated.  She was transferred to ED for further evaluation a 1148.  patient walked to ED to be evaluated for allergic reaction. Pt. reports having an 1100 vaccine appointment. Pt. received vaccine, then c/o left arm redness/swelling.  HISTORY OF PRESENT ILLNESS: patient is a 36y female who presents to the ED with an allergic reaction. Pt reports she received the Pfizer COVID-19 vaccine this morning at 1100, first dose, and noted a rash along the left arm where the injection site was. Pt notes she received the first dose of the Pfizer vaccine. Pt documents a rash along the left arm which she described as "itchy and tingling."  Patient initially had an area of redness following the injection site and then it extended down her entire arm to the wrist.  She states that she was wearing a tighter shirt and they had her change into a loose scribed top.  Patient denies any tongue swelling, throat swelling, itching, sneezing, syncope, presyncope, chest pain, shortness of breath double cough, nausea, or vomiting.  No prior history of allergic/anaphylactic reactions. Patient was monitored for 1 hr and had significant improvement of symptoms.  She was discharged in good condition and to return with any new, concerning, worsening symptoms. Advised to follow up with PCP in 2-3 days.  Dx: acute allergic reaction to COVID-19 Vaccine Provided Rx for Benadryl and Pepcid  Seen by PCP 1/22/2021 and internal reported filed, prompting VAERS report
Initial report received from a non-healthcare professional on 06 November 2013. A 57-year-old female patient whose concomitant medications were not reported, received a dose of FLUZONE (lot number: UH908AA, expiry date: 30 June 2014) on right arm via subcutaneous route on an unspecified date in October 2013. Patient stated that FLUZONE administered subcutaneous instead of intramuscular. Patent stated that over 3-4 days after vaccination in the right arm developed a 2-3 inch in diameter red inflamed area, and warm to touch at site of injection. The events (vaccination site inflammation and vaccination site warmth) were resolved.  List of documents held by sender: none.
The first two days she ran a fever(100.2), was extremely sleepy, lost appetite. At the sight of the injection on her left arm she had a hard knot that was warm to the touch. At 10 days she developed a blotchy rash/hives aroung the injection sight that by day 14 had spread to her enitre body from the bottoms of her feet, all over her trunk, legs, arms, and cheeks.  She looks like she has roseacia, the rash is warm and she has been scratching.  This is day 17 and she is progressively getting redder, not better.
This spontaneous report has been received from a nurse practitioner regarding a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated VARIVAX dose 1, (dose, lot # and expiry date unknown). On 09-APR-2008, the patient received improperly stored VARIVAX dose 2, from lot # 658023/0824U, expiry date 25-MAY-2009 (dose, vaccination site, route unknown). No adverse effects were reported. The reporter stated that inconsistences in storage temperature were identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of several reports received from the same reporter. Additional information has been requested.
Really adverse side effects; woke her up at night; arm was extremely painful, could hardly lift it; chills; fever from 98-101; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Really adverse side effects), SLEEP DISORDER (woke her up at night), MYALGIA (arm was extremely painful, could hardly lift it), CHILLS (chills) and PYREXIA (fever from 98-101) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 000621a) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Concomitant products included METOPROLOL and WARFARIN SODIUM (COUMADIN) for an unknown indication.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced ADVERSE EVENT (Really adverse side effects), SLEEP DISORDER (woke her up at night), MYALGIA (arm was extremely painful, could hardly lift it), CHILLS (chills) and PYREXIA (fever from 98-101). At the time of the report, ADVERSE EVENT (Really adverse side effects), SLEEP DISORDER (woke her up at night), MYALGIA (arm was extremely painful, could hardly lift it), CHILLS (chills) and PYREXIA (fever from 98-101) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient.  A 77-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 16Feb2021 at 13:30 as dose 1, single (Batch/Lot number: unknown), in left arm and on 25Aug2021 at 14:30 as dose 2, single (Batch/Lot number: unknown) at the age of 76 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Borderline >cholesterol" (unspecified if ongoing); "constapaton" (unspecified if ongoing); "Fx of 3 ribs 8,9,10, 2021 we'll healed", stop date: 2021, notes: Fx of 3 ribs 8,9,10, 2021 we'll healed. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
PATIENT HAD REDNESS THAT SPANNED FROM ELBOW TO SHOULDER WITHOUT ITCHING OR PAIN THAT HAVE PROGRESSED SINCE THE VACCINATION DATE 2/28/20 TO PRESENT 3/9/2020
Patient reported over phone redness spreading down arm pain injection site to elbow, swelling and itching, second night tingling in hand but not afterwards. Pt recommended antihistamine OTC and MD visit.
Patient woke up on day 2 (2-1-2019) with right side of face red and swollen. The symptoms went away after 5 hours. Reported by Mother. The pt did not take any treatment.
Magnet stick to her injection arm in the left upper arm; This spontaneous case was reported by a consumer and describes the occurrence of UNEVALUABLE EVENT (Magnet stick to her injection arm in the left upper arm) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0090T1A and 007C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jun-2021, the patient experienced UNEVALUABLE EVENT (Magnet stick to her injection arm in the left upper arm). At the time of the report, UNEVALUABLE EVENT (Magnet stick to her injection arm in the left upper arm) outcome was unknown.            No treatment and concomitant medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Patient second name is updated.; Sender's Comments: Very limited information regarding this event has been provided at this time. Further information has been requested.
PATIENT RECIEVED FIRST DOSE OF COVID (MODERNA LOT 006B21A) ON 3/16/21 CLINIC AND THEN RECIEVED ANOTHER DOSE AT THE FACILITY CLINIC ON 3/24/21
pt recvd vax;40 days later, devel erythematous based rash w/out vesicles;30aug95 fever 99.2 & pos strep test but rash did not appear to be similar to a strep type;
No additional adverse event; Patient received the pediatric dose of VAQTA (also reported as Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) conflicting information) instead of adult dose; Patient received the pediatric dose of VAQTA  (also reported as Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB)  instead of adult dose; This spontaneous report was received from a nurse and refers to a 66-year-old female patient. The patient's concurrent conditions, drug reaction or allergies, pertinent medical history and concomitant therapies were not reported.    On 04-APR-2023, the patient was vaccinated with a pediatric dose of hepatitis a vaccine, inactivated(VAQTA) (also reported as Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) conflicting information), intramuscularly, in the right deltoid, lot # W028555, expiration date 10-JUL-2024,  for prophylaxis; instead of adult dose (incorrect dose administered and underdose). This error occurred during preparation and administration of vaccine. No additional adverse events and nor product quality complain were reported.  This is one of two reports from the same reporter. ; Sender's Comments:  US-009507513-2305USA000680:
headaches; slight fever; body aches; nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headaches), PYREXIA (slight fever), PAIN (body aches) and NAUSEA (nausea) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced HEADACHE (headaches), PYREXIA (slight fever), PAIN (body aches) and NAUSEA (nausea). At the time of the report, HEADACHE (headaches), PYREXIA (slight fever), PAIN (body aches) and NAUSEA (nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication provided.
Symptoms including time of vaccination and onset time of symptoms:  18 y/o male with hx of previous allergic reactions c/o mild SOB, "throat swelling" sensation 30 mins post first dose of Pfizer @ 11:23am, time of vaccine 10:53am. Pt speaking in full sentences, no acute distress/stridor/wheezing/lip swelling/rash on exam. Lungs CTAB. Pt immediately given 50mg Benadryl IM @ 11:23am Benadryl. Pt immediately reported improvement of symptoms, states SOB resolved and 60% improvement of throat swelling sensation @ 11:27am. Pt monitored an additional 30 mins and upon discharge pt reports COMPLETE resolvement of symptoms@ 11:53am. Pt instructed to call UBER/LYFT/friend for transport and to not operate vehicle for Benadryl can make him drowsy.Upon dc pt in NAD, lungs CTAB. No stridor/wheezing on exam.
very sore shoulder and neck; very sore shoulder and neck; headache; This is a spontaneous report from a contactable consumer (patient) reported herself. A 70-years-old female patient received BNT162B2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, lot number: unknown, expiry date: unknown) via an unspecified route, administered in right arm on 17May2021 at 11:00 (at the age of 70-years-old) as dose 1, single for COVID-19 immunization. The patient's medical history included hypertension, bad kidney, bad lungs, bad heart, bad liver from an unknown date and unknown if ongoing. She had no family history. Concomitant medication included 17 pills a day (further not clarified). No other vaccines within 4 weeks prior to COVID-19 vaccine. On an unspecified date, the patient experienced very sore shoulder and neck, headache. The outcome of events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Received Pfizer COVID dose #2 on 2/6/21 at 0700. Began to experience general pruritus at 2100 and "scratchiness of throat". This morning he developed urticaria predominantly to right arm, upper chest.
Constant bilateral tinnitus of varying degrees of severity from strong to debilitating, with episodes of deafening/muffled, pressure-like sensation in the left ear.  During these events of functional loss of hearing in the left ear, the tinnitus is often debilitating, affecting my ability to participate in a conversation, concentrate or even perform common tasks. These episodes last from hours to days.   Tylenol 1000mg PO has not remedied the symptoms
The day after the shot, I woke up with shingles (Herpes Zoster) on the right side of my body. I had one lesion on the right side of my neck, two on my right breast, one the right of my abdomen, and many on my genitals. It lasted for 7 days.   After the seventh day, I woke up to COVID arm.  My entire upper left arm, had a red and itchy patch. The redness lasted 8 days, but the itchiness lasted 21 days.
After 1 hour of receiving the vaccine I started to experience a headache that lasted the entire day, by 5pm of the same day I began to have chills and by 2am of the next day I had a fever 103.1 F and my left arm was incredibly sore that I couldn't even roll over my bed. The fever lasted until 7am in the morning, then the second day on January 30th i had too much fatigue and I could barely move my left arm and had those symtops the entire day and I felt like I had a little of cough and my voice was dysphonic. On January 31st I felt like myself again.
?SIDS/SUIDS. Death cert. not yet avail. For autopsy report, contact Medical Examiner or HCP.
Parent lied about patient's age on intake form. When trying to bill for the vaccine the pharmacy called Pharmacy where patient form indicated they received their first dose.  Pharmacy informed us that the patient was only 11 years old.
a patient received a expired dose of VAQTA; This spontaneous report has been received from an administrator referring to a patient of unknown age and gender. The patient's pertinent medical history, drugs reactions or allergies and concomitant medications were not reported.  On 27-JAN-2022, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) as prophylaxis (strength, dose, frequency, route of administration, and anatomical injection site were unknown by the reporter; lot number T017179 has been verified to be a valid lot number for hepatitis a vaccine, inactivated, with an expiration date on 26-OCT-2021) (expired product administered).
1 st shot: Swelling in arm/Pain, headache. Tired, Muscle aches. lasted 2 days. (No Fever). 2 nd shot:  Swelling in arm/Pain, Extreme Headache, Fever 101.5, Extreme muscle aches, nausea, vomiting. These symptoms lasted 2 days.
Child looked "out of it/blank". Then went limp. No color change. Lasted approximately 1 minute. Then within next few minutes back to normal self. Admitted overnight for observation.  11/26/2007 MR received for o/n observation 9/15/2007 with DX: Febrile Convulsion.  Fever.  Hx of congential heart disease.   Per parent, child had been warm to touch x 1 day.  Infant appeared to have a tonic/clonic type episode lasting <1 minute.  No color change. PE showed diaper rash and systolic murmur, otherwise WNL.
Side effects reactions; Allergic reaction; Missed Dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects reactions), HYPERSENSITIVITY (Allergic reaction) and PRODUCT DOSE OMISSION ISSUE (Missed Dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects reactions), HYPERSENSITIVITY (Allergic reaction) and PRODUCT DOSE OMISSION ISSUE (Missed Dose). The patient was treated with EPINEPHRINE (EPIPEN) for Allergic reaction, at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (Side effects reactions), HYPERSENSITIVITY (Allergic reaction) and PRODUCT DOSE OMISSION ISSUE (Missed Dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided by reporter. The patient experienced a severe allergic reaction after receiving the Moderna vaccine. After 18 min of vaccination the medical personnel of a health department had to apply an EpiPen to shut down the allergic reaction.The patient returned they recommended her not to take the second shoot and go for of of Johnson&Johnson.   Most recent FOLLOW-UP information incorporated above includes: On 21-Sep-2021: Upon follow-up receipt: Event added.
I had some stiffness and uncomfortable in my chest near my heart. I requested a referral through email. I went to the urgent care and completed an ECG. They didn't find an unusual sinus rhythm and bloodwork to ensure I wasn't having a heart attack. There were some abnormalities in other tests. It was decided I should get a heart monitor for long-term monitoring and to get a stress test done. I got the heart monitor yesterday and have a stress test scheduled for 06/01/2022.
pt recv vax JAN97 & 25JAN97 pt exp fever of up to 105 which was not controlled w/APAP & upper resp infect sx;